• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Telehealth Startup VoCare Announces Partnership with Motorola

by Fred Pennic 06/08/2014 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

VoCare, Inc

VoCare, Inc.—Powered by Motorola offers a comprehensive telehealth product for the elderly and chronically ill that combines its MySimpleOne smart phone with unlimited voice, text, and data, along with a Personal Emergency Response System (PERS) safety button, medical peripherals; charging base and speakerphone, to form a comprehensive FDA cleared remote patient monitoring solution. The VoCare solution is offered directly to consumers as a pre-packaged kit that includes a combination of preloaded applications that can be used with medical peripheral devices, to provide remote patient monitoring of a patient by their own physician. As healthcare in this country migrates towards better care, more efficient and lower cost management solutions, VoCare provides a unique vehicle for this transformative trend. In addition, VoCare also offers the MySimpleOne senior advanced smartphone as a separate product as well as a telehealth application, HealthCareAnywhere, for use on all devices.

VoCare’s agreement with Motorola coincides with the completion of the company’s Series A Offering in which it successfully raised approximately $5 million. During this time, VoCare also secured US Patent # US 8,116,724; obtained FDA 510K approval; and completed clinical trials and proof of concept for the US market. Now that Series A is closed, VoCare has undertaken its Series B Offering prior to taking the company public, which in turn will allow it to bring on additional staff and launch the program nationally.

According to Dr. Ben Park, MD, the CEO of American Health Network, “VoCare provides four significant benefits for both provider and patient: improved patient care; enhanced personal safety; an overall reduction in the cost of care; and a new revenue stream for physicians who are willing to provide a plan of care.”

VoCare’s Chief Executive Officer and Founder Steven R. Peabody notes that, “VoCare brings a unique dynamic, as it comprehensively combines telehealth and remote patient monitoring, as well as medical alert, similar to ‘I’ve Fallen and I Can’t Get Up!’® in a manner that will allow doctors to track patient health and make ‘virtual house-calls.’ This creates a new approach to patient care inasmuch as it addresses the needs of an aging population while it enhances efficiency for healthcare organizations.” Peabody indicated that while he anticipates that this Offering will be completed in the next few months, “in order to position the Company for future growth and expansion, it is VoCare’s intention to become a publicly traded company at the close of this fundraising series.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |